Chronic Inflammatory Bowel Disease
Conditions
Keywords
crohn disease, ulcerative colitis, physical activity
Brief summary
Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies, adapted physical activity (APA) has demonstrated its beneficial impact, particularly on fatigue, anxiety, digestive symptoms, and the overall quality of life of patients with IBD. The real-world implementation of APA remains insufficient, primarily due to limited patient adherence to this prescription. Patient therapeutic education (PTE) represents a potentially powerful lever for promoting engagement in APA by addressing barriers related to a lack of awareness (fear of symptom worsening) and lack of motivation. No dedicated study has specifically evaluated the effect of targeted PTE sessions on adherence to physical activity in IBD. The objective of the present feasibility study will be to determine whether a single therapeutic education session focused on the digestive and systemic benefits of APA has an impact on the rate of physical activity practice in the medium term among patients with IBD in clinical remission for at least 3 months.
Interventions
Patients will be asked to complete the questionnaires regarding bowel inflammation at enrollment, 6 months later, and 12 months later.
Patients will be asked to complete the physical activity questionnaire 6 months later and 12 months later.
Sponsors
Study design
Eligibility
Inclusion criteria
* Confirmed diagnosis of Inflammatory Bowel Disease * Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score \< 3 and no subscore \> 1) for at least 3 months * Social Security coverage
Exclusion criteria
* Pregnant or breastfeeding woman * Patient under legal guardianship * Cardiovascular or rheumatic conditions contraindicating participation in sports * Neurological conditions with residual deficits contraindicating participation in sports * Refusal or inability to consent to participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effectiveness of therapeutic education intervention on physical activity practice | 12 months after the inclusion | Measure the amount of metabolic equivalent or MET/Week (Metabolic Equivalent Task) at 12 months, based on the short-IPAQ questionnaire assessing physical activities reported by the patient over the last 7 days. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| study the impact on quality of life at 6 months | 6 months after the inclusion | measure of quality of life with the IBD disk questionnaires answers at 6 months |
| Study the impact on quality of life in 12 months | 12 months after the inclusion | measure of quality of life with the IBD disk questionnaires answers at 12 months |
| study the impact on fatigue reported at 6 months | 6 months after the inclusion | Measure of fatigue reported according to one of the items of the IBD Disk questionnaire at 6 months |
| study the impact on fatigue reported at 12 months | 12 months after the inclusion | Measure of fatigue reported according to one of the items of the IBD Disk questionnaire at 12 months |
| study the correlation between increased overall muscle strength and improved quality of life | 12 months after the inclusion | Measurement of estimated muscle strength using a hand grip test before and after intervention as part of annual malnutrition screening and response to the quality of life questionnaire |
| Study of the impact on the evolution of IBD activity at 6 months | 6 months after the inclusion | measurement of clinical activity in chronic inflammatory bowel disease at 6 months |
| Study of the impact on the evolution of IBD activity at 12 months | 12 months after the inclusion | measurement of clinical activity in chronic inflammatory bowel disease at 12 months |
| study the impact on the monitoring of the prescription of adapted physical activity | 12 months after the inclusion | Monitoring of the APA prescription estimated according to the proportion of patients who completed at least 12 APA sessions (i.e. 1 weekly session for 3 months) and the average number of APA sessions completed. |
Countries
France